|
|
| CCR2_MOUSE |
Ccr2 |
C-C chemokine receptor type 2 |
4.096e-65 |
0.34
|
| Q6P1E0_MOUSE |
Syk |
Tyrosine-protein kinase |
8.409e-30 |
0.33
|
| VACHT_RAT |
Slc18a3 |
Vesicular acetylcholine transporter |
4.344e-19 |
0.34
|
| Q8WQX9_9TRYP |
PDEB1 |
Phosphodiesterase |
7.807e-18 |
0.37
|
| NTR2_RAT |
Ntsr2 |
Neurotensin receptor type 2 |
6.661e-16 |
0.98
|
| OPRX_RAT |
Oprl1 |
Nociceptin receptor |
1.499e-14 |
0.30
|
| CCR2_HUMAN |
CCR2 |
C-C chemokine receptor type 2 |
1.943e-12 |
0.35
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
9.311e-12 |
0.36
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
3.135e-11 |
0.36
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
3.485e-11 |
0.36
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
6.793e-11 |
0.40
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
1.09e-10 |
0.35
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
5.012e-10 |
0.36
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
5.654e-10 |
0.39
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
6.339e-09 |
0.31
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
9.042e-09 |
0.31
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
2.867e-08 |
0.35
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.906e-07 |
0.31
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
2.256e-07 |
0.32
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
1.944e-06 |
0.35
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
4.402e-06 |
0.34
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
4.727e-06 |
0.34
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
6.481e-06 |
0.37
|